Concepedia

Author

Paul Hellstern

Clinical Research Atlanta

Also Known As

D A Beary, Eckhard Lechler, P A Hellstern, P Hellstern, P. Hellstern, Paul A Hellstern, Paul A. Hellstern, Paul Hellstern

30

Publications

2.4K

Citations

10

H-Index

19

Concepts

All Affiliations

Clinical Research AtlantaMedical University of ViennaHumanitas UniversityUniversity of California San DiegoThe University of Texas Health Science Center at San Antonio
PH

About

Paul Hellstern is an author at Clinical Research Atlanta specializing in medicine, inflammation, and hepatology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

1.8K

2

Gastroenterology

2

2

223

3

Hepatology

2

2

1.6K

4

Immunology

2

2

223

5

Health Sciences

1

1

438

Paul Hellstern

×

8

Publications

2.2K

Citations

8

H-Index

YearCitations

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba,

The Lancet

2019

1.2K

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue,

Journal of Hepatology

2020

438

Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial

Séverine Vermeire, William J. Sandborn, Silvio Danese,

The Lancet

2017

197

Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)

Silvio Danese, Séverine Vermeire, Paul Hellstern,

Gut

2017

174

CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients

Paul J. Pockros, Michael Fuchs, B. Freilich,

Liver International

2019

155

Effects of Long-Distance Running on Iron Metabolism and Hematological Parameters

D. Seiler, Donald Nagel, H. E. Franz,

International Journal of Sports Medicine

1989

49

Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II

Walter Reinisch, William J. Sandborn, Silvio Danese,

Journal of Crohn s and Colitis

2021

34

901a A Randomized, Multicenter Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Anti-MAdCAM Antibody PF-00547659 (PF) in Patients With Moderate to Severe Ulcerative Colitis: Results of the TURANDOT Study

Walter Reinisch, William J. Sandborn, Silvio Danese,

Gastroenterology

2015

26

Page 1